Resverlogix Announces Participation at the American College of Cardiology Scientific Sessions together with the World Congress of Cardiology Virtual BioSpace
Overnight Health Care: White House projects grim death toll from coronavirus | Trump warns of 'painful' weeks ahead | US surpasses China in official virus deaths | CDC says 25 percent of cases never show symptoms | TheHill The Hill
BRIEF-Bayer AG Says Xarelto Plus Aspirin Significantly Lowered Combined Risk Of Limb Ischemia And Major Cardiovascular Events In Patients With Symptomatic Peripheral Artery Disease Post Revascularization Reuters
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Peripheral Artery Disease: a Systematic Review and Meta-Analysis DocWire News
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Peripheral Artery Disease: a Systematic Review and Meta-Analysis DocWire News
BRIEF-Bayer AG Says Xarelto Plus Aspirin Significantly Lowered Combined Risk Of Limb Ischemia And Major Cardiovascular Events In Patients With Symptomatic Peripheral Artery Disease Post Revascularization Reuters
Landmark Phase 3 Study of Xarelto Plus Aspirin Shows Significant Benefit in Patients with Symptomatic PAD after Lower-Extremity Revascularization PharmaLive
Landmark Phase 3 Study of Xarelto Plus Aspirin Shows Significant Benefit in Patients with Symptomatic PAD after Lower-Extremity Revascularization PharmaLive
Landmark Phase 3 Study of Xarelto Plus Aspirin Shows Significant Benefit in Patients with Symptomatic PAD after Lower-Extremity Revascularization PharmaLive
Landmark Phase 3 Study of Xarelto Plus Aspirin Shows Significant Benefit in Patients with Symptomatic PAD after Lower-Extremity Revascularization PharmaLive
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Peripheral Artery Disease: a Systematic Review and Meta-Analysis DocWire News
Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients. StreetInsider.com
Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the CoronavirusOvertaxed healthcare systems will delay enrollment in some geographic locations BioSpace
Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent PublicationEpigenetic BET-inhibition to combat COVID-19 BioSpace
Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the CoronavirusOvertaxed healthcare systems will delay enrollment in some geographic locations BioSpace
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session The Trentonian
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session P&T Community
Global Peripheral Artery Disease Devices Market 2020 – 2025 Industry Dynamics, Segmentation, Regional Outlook and Competition Analysis Bandera County Courier
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session The Trentonian
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session The Trentonian
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session PRNewswire
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session P&T Community
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session Yahoo Finance
Israeli Ministry of Health Clears a Path to Allow Per Patient Compassionate Use Treatment of Covid-19 Patients with Pluristem's PLX Cells StreetInsider.com
Your Illinois News Radar » Pritzker: Stay at home starting tomorrow at 5; Orders municipalities to halt evictions; Postpones school reopening to April 8; Chicago closes parks & libraries; Governor addresses rumors The Capitol Fax Blog
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session P&T Community
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session P&T Community
Positive Results from Registrational Study of LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) in Advanced Endometrial Carcinoma Published in the Journal of Clinical Oncology KPVI News 6
Positive Results from Registrational Study of LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) in Advanced Endometrial Carcinoma Published in the Journal of Clinical Oncology The Trentonian
Global PAD Medical Device Market: industry share, size, trends, growth, investment analysis, development factors, future scope, challenges and forecast to 2026 News Tailored
Global PAD Medical Device Market: industry share, size, trends, growth, investment analysis, development factors, future scope, challenges and forecast to 2026 News Tailored